Viewing nowCombinationAlendronate Plus D Tablets
Sodium Alendronate Trihydrate 91.37mg · Cholecalciferol Concentrate Powder 53.33mg
Tablet · Prescription medication · Combination
Aliko Pharmaceutical Co., Ltd.

MFDS item code 201506027 · Approved 2015.08.26 · Insurance code 656003990
Treatment of osteoporosis in postmenopausal women and men
This medication is used to treat osteoporosis in postmenopausal women and men. Osteoporosis is a condition characterized by decreased bone density, increasing the risk of fractures; this medication helps strengthen bones to prevent fractures. Therefore, it is effective for the treatment of osteoporosis in both postmenopausal women and men.
Take 1 tablet of this medicine (70 mg/2800 IU or 70 mg/5600 IU) once weekly in the morning with a sufficient amount of water, at least 30 minutes before consuming food, beverages, or other medicines (see “General Precautions”). The appropriate dose for most patients with osteoporosis is 70 mg/5600 IU once weekly. The optimal duration of treatment has not been established. The safety and efficacy of this medicine for the treatment of osteoporosis are based on clinical data for 4 years. All patients receiving bisphosphonates should be reassessed periodically to determine whether continued treatment is needed. In patients at low risk of fracture, discontinuation should be considered after 3~5 years of treatment. Patients who discontinue treatment should be reassessed periodically for fracture risk. Consumption of food within 30 minutes after taking this medicine, or at the same time, may reduce the absorption of alendronate and thereby decrease its efficacy. This medicine should be taken immediately after getting up in the morning, swallowed with a sufficient amount of water (170∼230 mL) to help the medicine reach the stomach quickly and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking this medicine and until after the first food intake. Do not take this medicine at bedtime or before getting up in the morning. Patients with insufficient calcium and vitamin D intake from food should take supplements (see Precautions for Use, 4. General Precautions, 2) Information to Be Provided to Patients (4)). Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, nursing home residents, and patients with chronic diseases) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndromes may need higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. Once-weekly administration of this medicine provides one week’s supply of vitamin D at daily amounts of 400 IU and 800 IU. If a patient taking 1 tablet of this medicine forgets to take it on the scheduled day, take 1 tablet the next morning, then resume taking it on the originally scheduled day and continue regularly once weekly thereafter. However, do not take 2 tablets on the same day. ○ Administration to elderly patients (65 years and older): No dose adjustment is necessary. ○ Administration to patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 35∼60 mL/min). However, use of this medicine is not recommended in patients with severe renal impairment (creatinine clearance less than 35 mL/min), as there is insufficient clinical experience.
○ Children and adolescents (under 18 years): The safety and efficacy in children and adolescents have not been established.
This medication may irritate the upper gastrointestinal mucosa and cause esophageal adverse reactions such as esophagitis, esophageal ulcers, and esophageal erosions. Sometimes this may worsen into esophageal obstruction or perforation, so if symptoms like dysphagia, odynophagia, pain behind the sternum, or heartburn occur, stop taking the medication and consult a doctor. When taking, it should be taken with a sufficient amount of water, and one should not lie down for at least 30 minutes after taking it. Patients with esophageal motility disorders or who cannot sit or stand upright for at least 30 minutes, those hypersensitive to the ingredients, patients with hypocalcemia, or those with certain genetic metabolic disorders should not take this medication. Those taking this medication should be cautious if they have gastrointestinal diseases, as gastrointestinal symptoms such as nausea, vomiting, abdominal pain, indigestion, constipation, and diarrhea may occur. Symptoms like musculoskeletal pain or cramps, headache, dizziness, and taste disturbances have also been reported. Before taking the medication, read the product leaflet carefully and take it according to a doctor's instructions, and it is advisable to take supplements if calcium intake is insufficient. This medication may interact with certain drugs, so caution is advised when taking it with calcium supplements or antacids, aspirin, or non-steroidal anti-inflammatory drugs. It should be administered cautiously in pregnant women, nursing mothers, and children, and is not recommended for patients with severely impaired kidney function. In case of overdose, hypocalcemia and gastrointestinal irritation symptoms may occur, so immediate consultation with medical personnel is required, and one should avoid inducing vomiting and maintain an upright position. This medication should be kept out of reach of children, and it is safe not to transfer it to another container.
esophagitis, esophageal ulcer, esophageal erosion, esophageal obstruction, esophageal perforation, bleeding, dysphagia, odynophagia, retrosternal pain, heartburn, gastric ulcer, duodenal ulcer, abdominal pain, nausea, indigestion, constipation, diarrhea, flatulence, gastroesophageal reflux, vomiting, abdominal distension, gastritis, musculoskeletal (bone, muscle or joint) pain, muscle cramps, headache, dizziness, altered taste, rash, erythema, anastomotic ulcer, urticaria, angioedema, myalgia, fatigue, weakness, fever, symptoms of hypocalcemia, peripheral edema, oro-pharyngeal ulcer, localized jaw necrosis, joint swelling, low-energy fractures of the femoral neck and other bones, dizziness, vertigo, itching, hair loss, Stevens-Johnson syndrome, toxic epidermal necrolysis, uveitis, scleritis, episcleritis, cholesteatoma of the external auditory canal, nasopharyngitis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. Additionally, it is best to store it at room temperature between 1°C and 30°C in a place that avoids direct light.
White to grayish-white oblong tablet
4 tablets/PTP
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationSodium Alendronate Trihydrate 91.37mg · Cholecalciferol Concentrate Powder 53.33mg
Tablet · Prescription medication · Combination
Aliko Pharmaceutical Co., Ltd.
CombinationSodium Alendronate Trihydrate 91.37mg · Cholecalciferol Concentrate Powder 53.33mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationSodium Alendronate Trihydrate 91.37mg · Cholecalciferol Concentrate Powder 53.33mg
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
CombinationSodium Alendronate Trihydrate 91.37mg · Cholecalciferol Concentrate Powder 53.33mg
Tablet · Prescription medication · Combination
Unimed Pharmaceutical Co., Ltd.
CombinationSodium Alendronate 91.37mg · Cholecalciferol Concentrate Powder 53.33mg
Tablet · Prescription medication · Combination
Jeil Pharmaceutical Co., Ltd.
Sodium Alendronate Hydrate · Cholecalciferol Concentrate Powder
Prescription medication · Combination
Youngjin Pharmaceutical Co., Ltd.
CombinationSodium Alendronate Trihydrate 91.37mg · Cholecalciferol Concentrate Powder 53.33mg
Tablet · Prescription medication · Combination
Yuyu Pharmaceutical Co., Ltd.
CombinationSodium Alendronate Trihydrate 91.37mg · Cholecalciferol Concentrate Powder 53.33mg
Tablet · Prescription medication · Combination
Jinyang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.